apomorphine has been researched along with Memory Disorders in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brosda, J; Fink, H; Franke, RT; Pertz, HH; Tarland, E | 1 |
| Antonio, CB; Betti, AH; da Rocha Pitta, I; do Rego, JC; do Rego, JL; Herzfeldt, V; Pitta, MGDR; Rates, SMK; Vaudry, D | 1 |
| Hamzehloei, L; Rajaei, Z; Rezvani, ME | 1 |
| Markou, A; Pitsikas, N | 1 |
| Liu, TD; Yang, HD; Yang, Z | 1 |
| Bartiromo, M; Bertolini, A; Ferrari, A; Genedani, S; Ottani, A; Renzo Botticelli, A; Saltini, S; Zaffe, D | 1 |
| Gilles, C; Luthringer, R | 1 |
| Agai-Csongor, E; Bielik, A; Domány, G; Galambos, J; Gémesi, L; Greiner, I; Gyertyán, I; Ignácz-Szendrei, G; Keseru, GM; Kiss, B; Laszlovszky, I; Laszy, J; Magdó, I; Nógrádi, K; Sághy, K; Schmidt, E; Vágó, I; Zájer-Balázs, M | 1 |
| Nabeshima, T; Noda, Y; Tang, YP | 1 |
| Baillet, C; Callizot, N; Guénet, JL; Poindron, P; Warter, JM | 1 |
| Agnati, LF; Biagini, G; Fuxe, K; Grimaldi, R; Merlo Pich, E; Solfrini, V; Toffano, G; Zoli, M | 1 |
1 review(s) available for apomorphine and Memory Disorders
| Article | Year |
|---|---|
Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs.
Topics: Apomorphine; Cognition Disorders; Dopamine Agonists; Excitatory Amino Acid Antagonists; GABA Modulators; Humans; Ketamine; Lorazepam; Memory Disorders; Models, Psychological; Muscarinic Antagonists; Panic Disorder; Psychotropic Drugs; Scopolamine; Tryptophan | 2007 |
10 other study(ies) available for apomorphine and Memory Disorders
| Article | Year |
|---|---|
Effects of 2-bromoterguride, a dopamine D
Topics: Animals; Antipsychotic Agents; Apomorphine; Cognition Disorders; Dopamine Agonists; Lisuride; Male; Memory Disorders; Phencyclidine; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Recognition, Psychology; Reflex, Startle; Schizophrenic Psychology; Social Behavior | 2018 |
PT-31, a putative α2-adrenoceptor agonist, is effective in schizophrenia cognitive symptoms in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Cognition; Disease Models, Animal; Dopamine Agonists; Imidazolidines; Male; Memory; Memory Disorders; Memory, Long-Term; Mice; Mice, Inbred Strains; Rats; Rats, Wistar; Receptors, Adrenergic; Schizophrenia; Schizophrenic Psychology | 2019 |
Effects of carvacrol and physical exercise on motor and memory impairments associated with Parkinson's disease.
Topics: Animals; Apomorphine; Cymenes; Disease Models, Animal; Male; Memory Disorders; Motor Activity; Oxidative Stress; Parkinson Disease; Physical Conditioning, Animal; Rats; Rats, Wistar | 2019 |
The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
Topics: Amino Acids; Animals; Apomorphine; Bridged Bicyclo Compounds, Heterocyclic; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Ketamine; Male; Memory Disorders; Neuropsychological Tests; Random Allocation; Rats, Wistar; Receptors, Metabotropic Glutamate; Recognition, Psychology; Spatial Memory | 2014 |
[Effect of dopamine receptor agonist apomorphine on scopolamine induced memory deficits in mice].
Topics: Animals; Apomorphine; Disease Models, Animal; Dopamine Agonists; Male; Memory Disorders; Mice; Scopolamine | 2014 |
Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage.
Topics: Animals; Apomorphine; Brain; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin-1; Kainic Acid; Learning; Male; Memory Disorders; Motor Activity; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Rats; Rats, Wistar; Sodium Oxybate | 2003 |
Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Binding, Competitive; Biological Availability; Brain; Catalepsy; Cognition; Humans; Indicators and Reagents; Male; Maze Learning; Memory Disorders; Quantitative Structure-Activity Relationship; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Stereotyped Behavior; Sulfonamides | 2007 |
Involvement of activation of dopaminergic neuronal system in learning and memory deficits associated with experimental mild traumatic brain injury.
Topics: Animals; Apomorphine; Benzazepines; Brain Injuries; Dopamine; Dopamine Agonists; Dopamine Antagonists; Exploratory Behavior; Haloperidol; Learning Disabilities; Male; Memory Disorders; Mice; Mice, Inbred Strains; Neurons; Retention, Psychology; Sulpiride | 1997 |
The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Electromyography; Female; Genes, Recessive; Immunohistochemistry; Indoles; Levodopa; Male; Memory Disorders; Mice; Mice, Inbred C3H; Mice, Neurologic Mutants; Motor Activity; Neurons; Parkinson Disease, Secondary; Postural Balance; Selegiline; Tyrosine 3-Monooxygenase | 2001 |
Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Brain Ischemia; Choice Behavior; Corpus Striatum; Dopamine and cAMP-Regulated Phosphoprotein 32; G(M1) Ganglioside; Germ-Free Life; Hippocampus; Male; Memory Disorders; Nerve Tissue Proteins; Phosphoproteins; Prosencephalon; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1992 |